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ABSTRACT 
This study was performed to evaluate the visual, refractive, and aberration measurement results of 2 implants, 
including Intacs Intracorneal Ring Segments (ICRS) and phakic Toric Implantable Collamer Lens (TICL), in patients 
with moderate Keratoconus (KCN). In this retrospective cross-sectional study, 30 patients with KCN with a mean 
age of 29.83 years were included in 2 groups, including the Intacs Intracorneal Ring Segments (ICRS) group and 
the phakic Toric Implantable Collamer Lens (TICL) group. Preoperative data as well as 6-month, 1-, 2-, 3- and 4-
year follow-up data after the operation were collected and analyzed with the SPSS software (ver. 23.0, SPSS, Inc., 
Chicago, IL), using the paired t-test, independent t-test, repeated measures Analysis of Variance (ANOVA), and 
one-way ANOVA. This study included 30 patients with KCN with a mean age of 29.83 years and range of 25 to 35 
years, including 17 males with a mean age of 30.11 years and 13 female with a mean age of 29.25 years. Except 
for preoperative Uncorrected Distance Visual Acuity (UCDVA), Spherical Equivalent (SE) and astigmatism, there 
was a significant difference between the 2 groups regarding other variables. The TICL group had a significantly 
better UCDVA and Best Corrected Distance Visual Acuity (BCDVA) in all post-operative follow-ups, and SE and 
astigmatism values were significantly lower in all post-operative follow-ups when compared with the ICRS group. 
There was a significant reduction in corneal and total coma as well as internal trefoil aberrations (P<0.01, P<0.01, 
and P=0.014, respectively) in the ICRS group, and TICL led to a significant reduction in internal trefoil aberration 
with P<0.03. Comparison of the 2 groups revealed a significant difference in corneal spherical (P<0.01) and total 
coma (P=0.02) aberrations and no significant differences in other HOA. Both ICRS and TICL are useful in patients 
with moderate KCN. However, TICL appears to have more stable and predictable vision results. 
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INTRODUCTION 
Keratoconus (KCN), as an asymmetric non-inflammatory 
ectatic disorder of the cornea, is almost always bilateral. 
In this disorder, progressive stromal thinning leads to 
conic deformation and protrusion of cornea at the 
thinnest point. Prevalence of KCN varies amongst 
different studies from 1 per 2000 to 5.4 per 10000 
individuals [1],[2]. Progression of KCN begins with 
progressive deterioration of Visual Acuity (VA), which is 
not corrected with spectacles [2],[3].  
Based on severity of KCN, there are different modalities 
of treatment, including strengthening procedures, optical 
optimization, and combined procedures [4]. In mild to 
moderate stages, spectacles [1] and hard contact lenses 
[5] are appropriate options. However, in advanced 
stages, keratoplasty [6] may be required, with the 
disadvantage of being costly, requiring lifelong follow-up, 
risk of graft-rejection or infection and suture-related 
complications  [7]. Therefore, other safe and effective 
treatment modalities, including implantation of Intacs 
Intracorneal Ring Segments (ICRS) and phakic Toric 
Implantable Collamer Lens (TICL), have been introduced 
[8],[9],[10],[11],[12],[13],[14],[15],[16],[17],[18],[19],[20]. 
Besides improvement of VA, attention to quality of vision 
is also important. By assessment of ocular Higher-Order 
Aberrations (HOA), a wave-front analyzer could evaluate 
optical quality and irregular astigmatism [21]. Several 
studies have evaluated optical aberrations in patients 
with KCN and revealed increased HOA, especially coma 
and spherical aberrations. Significant increase in HOA 
results in reduced VA, which is not correctable with 
spectacles or conventional contact lenses [22],[23],[24].  
The current study aimed at evaluating visual, refractive, 
and aberration measurement values (corneal, internal 
optics and total aberrations), preoperatively and at the 6-
month, and 1-, 2-, 3- and 4-year follow-up in TICL and 
ICRS implantation. 
 
MATERIALS AND METHODS 
This retrospective cross-sectional study was conducted 
on one eye of 30 patients with non-progressive (8 
months prior to surgical procedure) moderate KCN, aged 
25 to 35 years, who had undergone ICRS (Intacs, Addition 
Technology Inc., Fremont, California, USA) or TICL (ICL; 
STAAR Surgical, Nidau, Switzerland) implantation at 
Negah Eye Hospital, Tehran, Iran, by a single surgeon (SH. 
R.) and were followed-up postoperatively for the 
subsequent 4 years. Ethical approval was received from 
the Ethical Committee of Shahid Beheshti Medical 
University and all subjects signed informed consent 
forms. Diagnosis of KCN was based on the Amsler–
Krumeich classification [25]. Patients' VA was measured 
by the Snellen VA chart, based on the logMAR scoring 
system. Furthermore, refraction was assessed with auto-
refraction (Topcon RM800, USA) and aberrometry 
measurement was done with the iTrace (ray-tracing; 
Tracey Technologies, Houston, TX).  
The inclusion criteria were having complete medical files 
available at Negah Eye Hospital; lack of progression of 
KCN;  visual dissatisfaction with spectacles; contact lens 
intolerance; age of ≥ 25 years; Best Corrected Distance 
Visual Acuity (BCDVA) log MAR 0.4 (equivalent 20/40); 
maximum of 58 diopters of keratometry; Intraocular 
Pressure (IOP) of less than 20 mm Hg with Anterior 
Chamber Depth (ACD) of at least 3 mm, measured from 
the endothelium of the cornea; anterior chamber angle 
of >30°; and corneal endothelial cell density proportional 
to patient's age of at least 2000 mm².  
The exclusion criteria were having the thinnest corneal 
thickness of ≥ 380 µm; history of previous intraocular 
surgery;  history of herpetic corneal infections; lack of 
ocular media clarity, such as the presence of corneal scar 
or cataract; the presence of ocular diseases, such as 
glaucoma, active vernal kerato-conjunctivitis, intraocular 
inflammation, and retinal diseases except for KCN;  
history of  systemic diseases, such as diabetes mellitus, 
immune deficiency, and collagen vascular disease, which 
could delay corneal wound healing; drug history of 
sumatriptan, amiodarone, and isotretinoin; being 
pregnant or breastfeeding; and  having files with 
incomplete information or data belonging to a health 
care center other than Negah Eye Hospital.  
Preoperative as well as 6-month, and 1-, 2-, 3- and 4-year 
follow-up data were collected and analyzed with the 
SPSS software (ver. 23.0, SPSS, Inc., Chicago, IL), using the 
paired t-test, independent t-test, repeated measures 
Analysis of Variance (ANOVA), and one-way ANOVA. The 
paired t-test was used to measure pre- and post-
operative differences; independent t-test was used to 
assess the mean difference between ICRS and TICL 
groups; repeated measures ANOVA test was used to 
compare pre- and post-operative values; and one-way 
ANOVA was used to compare the values between the 2 
groups. P values of less than 0.05 were considered 
significant. 
 
RESULTS 
The current study was conducted on one eye of 30 
patients with KCN and a mean age of 29.8 years and a 
range of 25 to 35 years. The sample included 17 males 
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with a mean age of 30.1 years and 13 female with a 
mean age of 29.2 years. In the TICL group, there were 7 
males and 8 females with a mean age of 32.9 and 30.5 
years, respectively, and in the ICRS group, there were 6 
males and 9 females with a mean age of 28.55 and 27.33 
years, respectively. 
Table 1 shows mean ± Standard Deviation (SD) of 
preoperative as well as 6-month, and 1-, 2-, 3- and 4-year 
postoperative BCDVA, UCDVA, Spherical Equivalent (SE), 
and astigmatism values of the ICRS and TICL groups. As 
revealed in this table, except for preoperative UCDVA, 
SE, and astigmatism, there was a significant difference 
between the 2 groups regarding the other variables. 
Patients in the TICL group showed significantly better 
UCDVA and BCDVA during all post-operative follow-ups, 
and SE and astigmatism values in this group were 
significantly lower in all post-operative follow-ups when 
compared with the ICRS group, which implies better 
postoperative results in the TICL group. 
Table 2 and 3 show values of corneal, internal, and total 
HOA in the preoperative assessment as well as 6-month, 
and 1-, 2-, 3- and 4-year postoperative follow-ups  for  
ICRS and TICl groups, respectively.  There was a 
significant reduction in corneal and total coma as well as 
internal trefoil aberrations (P<0.01, P<0.01, and P=0.014, 
respectively) in the ICRS group (Table 2) and TICL led to a 
significant reduction in internal trefoil aberration with a P 
value of <0.03 (Table 3). Between-group comparison 
revealed a significant difference in corneal spherical 
(P<0.01) and total coma (P=0.02) aberrations (Table 3). 
However, no significant difference was observed in other 
HOA. 
 
 
Table 1. Pre and Post-Operative Vision and Refraction Results in the Intacs Intracorneal Ring Segments (ICRS) and Phakic Toric 
Implantable Collamer Lens (TICL) Groups 
Variable Mean (SD) P-value 
Group ICRS Group TICL 
LogMar UCDVA (Snellen) 
Pre-operative 0.65 (0.22) 0.82 (0.30) 0.09 
6 months post-operative 0.39 (0.08)* 0.11 (0.08)* <0.01 
1 year post-operative 0.39 (0.09)* 0.13 (0.10)* <0.01 
2 years post-operative 0.40 (0.13)* 0.10 (0.10)* <0.01 
3 years post-operative 0.43 (0.12)* 0.09 (0.08)* <0.01 
4 years post-operative 0.41 (0.12)* 0.10 (0.07)* <0.01 
LogMar BCDVA (Snellen) 
Pre-operative 0.37 (0.11) 0.15 (0.11) <0.01 
6 months post-operative 0.32 (0.08)* 0.09 (0.11)* <0.01 
1 year post-operative 0.35 (0.09) 0.04 (0.17)* <0.01 
2 years post-operative 0.34 (0.09)* 0.07 (0.15)* <0.01 
3 years post-operative 0.34 (0.10)* 0.06 (0.14)* <0.01 
4 years post-operative 0.33 (0.09)* 0.09 (0.14)* <0.01 
Spherical Equivalent (D) 
Pre-operative -5.70 (3.14) -8.57 (4.86) 0.06 
6 months post-operative -3.65 (1.39)* -0.85 (0.29)*  <0.01 
1 year post-operative -3.67 (1.32)* -0.97 (0.26)* <0.01 
2 years post-operative -3.57 (1.42)* -0.70 (0.19)* <0.01 
3 years post-operative -3.58 (1.28)* -0.75 (0.23)* <0.01 
4 years post-operative -3.15 (2.19)* -0.73 (0.26)* <0.01 
Astigmatism (D) 
Pre-operative -6.25 (2.93) -4.83 (2.06) 0.14 
6 months post-operative -4.67 (1.97)* -1.05 (0.74)* <0.01 
1 year post-operative -4.10 (2.81)* -0.97 (0.55)* <0.01 
2 years post-operative -4.03 (2.82)* -1.00 (0.58)* <0.01 
3 years post-operative -4.17 (2.81)* -1.02 (0.51)* <0.01 
4 years post-operative -4.98 (1.68)* -1.00 (0.53)* <0.01 
SD= standard deviation; ICRS= Intacs intracorneal ring segments; TICL=phakic toric Implantable    Collamer Lens; 
UCDVA=uncorrected distance visual acuity; BCDVA= best corrected distance visual acuity; Snellen= Snellen visual acuity chart; 
D= diopters. *= P values less than 0.05.  
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Table 2. Visual and Refractive Values Pre and Postoperatively in Intacs and Toric Implantable Collamer Lens Groups 
Variable (Mean ± SD) Post-operation P-value 
 Pre-operation 6 months 1 Year 2 Year 3 Year 4 Year  
Corneal        
Coma 1.70 (0.35) 1.21 (0.27) 1.26 (0.29) 1.28 (0.27) 1.28 (0.26) 1.29 (0.27) <0.01 
Spherical 2.27 (0.74) 2.27 (0.75) 2.27 (0.76) 2.27 (0.74) 2.30 (0.77) 2.27 (0.75) 0.51 
Trefoil 0.44 (0.19) 0.43 (0.17) 0.43 (0.18) 0.43 (0.18) 0.42 (0.18) 0.43 (0.18) 0.26 
Internal        
Coma 0.92 (0.14) 0.90 (0.13) 0.93 (0.18) 0.93 (0.18) 0.96 (0.23) 0.97 (0.23) 0.11 
Spherical 1.90 (0.63) 1.91 (0.61) 1.91 (0.61) 1.91 (0.59) 1.91 (0.55) 1.90 (0.56) 0.99 
Trefoil 0.43 (0.25) 0.33 (0.14) 0.32 (0.13) 0.32 (0.13) 0.33 (0.13) 0.34 (0.13) 0.014 
Total        
Coma 1.42 (0.28) 1.05 (0.17) 1.27 (0.25) 1.38 (0.26) 1.31 (0.25) 1.26 (0.24) <0.01 
Spherical 2.62 (0.58) 2.13 (0.69) 2.22 (0.62) 2.21 (0.54) 2.21 (0.54) 2.18 (0.57) 0.27 
Trefoil 0.43 (0.20) 0.40 (0.20) 0.42 (0.20) 0.42 (0.19) 0.41 (0.19) 0.40 (0.19) 0.59 
     SD= standard deviation; ICRS= Intacs Intracorneal Ring Segments. 
     *= P values less than 0.05. 
 
Table 3. Aberrometry Values in the Toric Implantable Collamer Lens Group 
Variable Pre-operation 
Post-operation 
P1-value P2-value* 
6 months 1 Year 2 Year 3 Year 4 Year 
Corneal         
Coma 1.31 (0.28) 1.31 (0.28) 1.32 (0.33) 1.29 (0.31) 1.31 (0.30) 1.34 (0.29) 0.93 0.76 
Spherical 2.34 (1.04) 2.34 (1.04) 2.34 (1.03) 2.32 (0.97) 2.36 (0.94) 2.37 (0.94) 0.80 <0.01 
Trefoil 0.42 (0.15) 0.42 (0.15) 0.41 (0.14) 0.40 (0.14) 0.39 (0.15) 0.39 (0.15) <0.21 <0.11 
Internal         
Coma 0.90 (0.18) 0.90 (0.18) 0.91 (0.11) 0.92 (0.14) 0.94 (0.16) 0.90 (0.18) 0.91 0.34 
Spherical 1.90 (0.87) 1.90 (0.87) 1.90 (0.85 1.91 (0.83) 1.90 (0.75) 1.90 (0.87) 0.99 0.99 
Trefoil 0.34 (0.11) 0.34 (0.11) 0.40 (0.10) 0.35 (0.12) 0.34 (0.11) 0.34 (0.11) 0.03 0.74 
Total         
Coma 1.10 (0.18) 1.10 (0.18) 1.16 (0.20) 1.15 (0.18) 1.13 (0.12) 1.13 (0.12) 0.17 0.02 
Spherical 2.28 (1.05) 2.28 (1.05) 2.27 (1.05) 2.29 (1.04) 2.73 (1.03) 2.27 (1.03) 0.52 0.40 
Trefoil 0.41 (0.13) 0.41 (0.13) 0.42 (0.11) 0.42 (0.12) 0.41 (0.12) 0.41 (0.12) 0.98 1.00 
SD= standard deviation; TICL=phakic Toric Implantable Collamer Lens; ICRS= Intacs intracorneal Ring Segments; HOA= Higher Order 
Aberrations. 
P1 value: In TICL group and P2 value: Comparison between ICRS and TICL groups. 
     *= P values less than 0.05. 
 
DISCUSSION 
Results of the current study revealed that ICRS and TICL 
were both useful and effective in patients with KCN, yet 
TICL seemed to have better and more predictable VA 
results in moderate non-progressive cases.  Despite 
recent advances, treatment of KCN still remains a 
challenge. Treatments, such as spectacles and contact 
lenses, although used for many mild cases, are not 
appropriate for many other patients as they do not have 
the proper BCDVA or tolerance for their use.  Many 
patients, who have not resolved their visual impairment 
with non-surgical methods, can be treated with 
approaches, such as ICRS or TICL implantation, to prevent 
or at least delay keratoplasty. This retrospective study 
investigated VA, refractive, and aberrometry changes 
following ICRS and TICL insertion. According to a 
comprehensive literature review, this study was one of 
the few long-term post-operative follow-ups of patients 
with non-progressive KCN (8 months prior to surgery) 
[18],[26],[27],[28],[29]. Significant improvement of 
UCDVA, which was noted in both groups of this study, is 
one of the most important parameters in clinical 
evaluations [18]. In the current study, the TICL group had 
significantly better UCDVA in all post-operative follow-
ups. These results could be partly explained by the 
significantly lower amount of residual SE in all post-
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operative follow ups in the TICL group, so that the 
amount of residual SE, 4 years post-operatively, in the 
TICL and ICRS groups was -0.73 D and -3.15 D, 
respectively.  This high prediction capacity of the TICL is 
due to the precise positioning of the Intraocular Lens 
(IOL), which is confined to a narrow space between the 
posterior surface of the iris and the anterior surface of 
the crystalline lens in ciliary sulcus. It is worth noting that 
problems of accurate refraction and keratometry in 
patients with KCN are important issues, which also 
influence accurate measurement of IOL power [26]. 
Therefore, repeated refraction and keratometric 
measurements are recommended in these cases. Also, 
the rate of postoperative residual astigmatism was 
improved with both methods during all post-operative 
follow ups, which was significantly better in the TICL 
group. This lower post-operative residual astigmatism in 
the TICL group could be attributed to the small corneal 
incision, because these lenses require only a 3-mm 
peripheral corneal incision for insertion, which ultimately 
results in less post-operative astigmatism [30]. 
Improvement in BCDVA ranged from 0.37 ± 0.11 to 0.33 
± 0.09 and from 0.15 ± 0.11 to 0.09 ± 0.14, pre- and post-
operatively in the ICRS and TICL groups, respectively, 
based on Log MAR, which indicates the safety and 
effectiveness of such methods.  
Implantation of intracorneal rings, such as Intacs, which 
is the method of choice for treating patients with KCN, is 
based on corneal shape change. In the current study, 
although the amount of myopia and astigmatism 
decreased significantly following ICRS, this reduction was 
significantly less than that of TICL. In addition, ICRS had 
lower predictive refractive results, especially at higher 
values, which is in line with a number of previous studies 
[28],[30].However, the predictability of TICL [18] results 
has been confirmed in recent studies [31],[32],[33]. 
 The reduction in VA of patients with KCN is not due to 
spherocylindrical refractive errors (lower order 
aberrations), yet is rather the result of a wider range of 
HOA. This could be explained explicitly by the fact that in 
many cases, the spectacle is not capable of perfect 
refinement of VA. This has led some scholars to modify 
the typical Amsler–Krumeich classification, based on 
coma aberration [34]. In KCN, the coma aberration, 
especially the vertical type, as well as trefoil and tetrafoil 
aberrations, appear to be the dominant ones 
[35],[36],[37],[38],[39],[40]. In the current study, ICRS 
significantly reduced corneal coma aberration, while it 
significantly improved spherical aberration in comparison 
with TICL, which ultimately led to a reduction in total 
coma aberration. However, TICL is significantly more 
effective in reduction of trefoil aberration and does not 
have much effect on other HOA. The justification for 
these changes in HOA could be explained by examining of 
the Zernike polynomials. This, in the TICL group, changes 
in peripheral corneal aberrations, such as trefoil, caused 
by peripheral corneal incision for its insertion. Whereas 
in the ICRS group, the reduction in central corneal 
aberrations, such as coma, is due to a change in the 
shape and regularity of the cornea and the location of 
Intacs insertion [28],[40]. Also, aberrations associated 
with center of cornea, such as coma, compared with 
peripheral aberrations, such as trefoil, have a greater 
effect on the quality of vision [38]. In the current study, 
there was no significant difference between the 2 groups 
regarding internal aberrations. Here it should be noted 
that corneal surface aberrations are the most important 
part of ocular errors, due to the greater difference in the 
refractive indices of air and cornea versus other 
refractive levels of the eye, and this is more pronounced 
in patients with KCN as the cornea is the main source of 
aberration [38]. Applegate et al. stated that ocular 
aberrations are not equal, so that different coefficients of 
Zernike polynomials with equal values in Root Mean 
Square (RMS) levels vary in degrees of effect on contrast 
sensitivity [36]. 
 In general, the relationship between HOA and the 
function of the visual system is very complicated and not 
fully understood [41]. In the ICRS group, there was a 
significant improvement in UCDVA, 6 months post-
operatively. However, observations during the 4-year 
post-operative follow-up did not show any significant 
changes, which is consistent with previous studies [38]. 
Also, in the TICL group, the postoperative outcome did 
not show significant change in the subsequent follow-up 
intervals, and was associated with relative stability, even 
at the end intervals; this stability and predictability was 
consistent with the results of Alfonso et al. [39]. 
Therefore, TICL insertion does not stimulate re-
development of the KCN due to changes in the 
performance of the visual system. This result is likely due 
to the mean age of 30 years of the patients and the 
stability of their refraction during a minimum period of 
12 months before surgery. Since this disease is usually 
more progressive at younger age and more stable at 
older age, similar to other studies, the current authors do 
not recommend the use of TICL in case of uncertainty 
about the progression of KCN [40]. Nowadays, TICL is 
available up to the diameter of -23 diopters for myopic 
correction and 6 diopters for correction of astigmatism, 
which, due to the placement of TICL lenses in the 
posterior chamber and the back of the iris, is better in 
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appearance and leads to greater patient satisfaction 
[28],[37]. It could be suggested that determining the 
exact criteria for selecting an appropriate patient has a 
key and determinant role. Furthermore, TICL has a high 
ability in correcting myopia and stigmatism, and in 
contrast to intra-corneal ring segments, it is more 
capable of correcting aberrations, [16],[15],[18]. It seems 
that a useful method in this area is to compare BCDVA 
with spectacles and hard contact lenses. Therefore, if 
there is a significant difference between these 2 
approaches, using TICL, the results of postoperative 
visual quality are less than expected. However, based on 
the long-term results of this 4-year follow-up study, TICL 
in correction of myopia and astigmatism was very 
effective in patients with moderate and non-progressive 
KCN, and post-operative results were almost constant 
over time and the ability to predict post-operative results 
was excellent. According to the current research and 
other studies [37]. using TICL lenses is an effective 
treatment for patients with non-progressive KCN, 
especially in those with good preoperative BCDVA. Based 
on the mentioned results, the authors recommend TICL 
for patients after taking in account other preoperative 
evaluations.  However, prospective studies and 
randomized controlled clinical trials with larger sample 
sizes are needed to provide more reliable evidence.  
It is necessary to mention that the use of TICL in 
advanced KCN, which is often associated with large 
amounts of corneal aberrations, more irregular corneas, 
and corneal opacities, is not applicable. The combination 
of intracorneal ring implants and phakic IOLs at 2 stages, 
with sequential aberrations and ametropia correction, 
may be used separately in progressive KCN patients with 
high myopia [15],[16]. However, in advanced KCN cases, 
lamellar keratoplasty is preferred.  
One of the limitations of this study was its retrospective 
design, low number of patients, and being limited to 
Tehran city. Also, for futures studies, it is better to use 
more comprehensive examinations, such as assessment 
of contrast sensitivity to obtain better and more citable 
results. 
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